1. Accueil >
  2. Director/PDMR Shareholding >
Nasdaq

Director/PDMR Shareholding

31-10-2018

DXS INTERNATIONAL PLC

Director Dealing

The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that it has been notified that the CEO, David Immelman, has purchased 19,802 Ordinary Shares at a price of 10p per share on 29 October 2018.

Following the transaction specified above Mr Immelman holds 3,657,539 Ordinary Shares representing 10.40% of the issued share capital of the Company.

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman   (Chief Executive)
DXS International plc		 01252 719800
david@dxs-systems.com
Wrecclesham House
Wrecclesham Road
Farnham
Surrey
GU10 4PS		  
www.dxs-systems.co.uk  


David Papworth
City & Merchant		 0207 101 7676
info@cityandmerchant.com
Level 17, Dashwood House
69 Old Broad Street,
London
EC2M 1QS		  

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.